|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation | |||||
| Depreciation | |||||
| Write off of deferred offering cost | |||||
| Common stock issued for license agreement | |||||
| Loss (gain) on disposal of fixed assets | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable and accrued expenses | |||||
| Net cash used in operating activities | |||||
| Purchase of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities: | |||||
| Payments of deferred offering costs | |||||
| Payments on notes payable | |||||
| Stock repurchased during stock split rounding | |||||
| Proceeds from subscription receivable | |||||
| Proceeds from exercise of warrants | |||||
| Proceeds from sale of common stock | |||||
| Net cash provided by financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents, at beginning of period | |||||
| Cash and cash equivalents, at end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Prepaid expense financed with note payable | |||||
| Reclassification of deferred offering costs to equity | |||||
| Common stock issued for subscription receivable | |||||
| Stock issued for stock split rounding | |||||
Loading...